# Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults

> **NCT02996695** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 62 (actual)

## Conditions studied

- Plasmodium Falciparum Infection

## Interventions

- **DRUG:** Artesunate
- **DRUG:** Chloroquine
- **BIOLOGICAL:** PfSPZ (NF54) Challenge
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02996695
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-06
- **Primary completion:** 2018-06-22
- **Final completion:** 2018-06-22
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2019-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02996695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02996695, "Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02996695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*